Clinical Trial

Precise Exercise Regimen for Cancer Care (PERCC): A Pilot Study

Study acronym: PERCC
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to test the feasibility of the Precise Exercise Regimen for Cancer Care (PERCC) exercise program in participants with stage II-III primary lung cancer.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-08-06
notable Primary completion moved earlier: 2027-09-30 -> 2027-03-30 2026-08-06
minor Completion moved earlier: 2028-09-30 -> 2028-03-30 2026-08-06
Trial Details
NCT Number NCT07412041
Lead Sponsor Dana-Farber Cancer Institute
Conditions Stage II Lung Cancer, Lung Cancer, Non-small Cell Lung Cancer, NSCLC
Enrollment 20 participants
Start Date 2026-01-22
Primary Completion 2027-03-30 (estimated)
Study Completion 2028-03-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-05